VR Logo

Suven Pharmaceuticals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

51 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 download pdf full AR
2020 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2019 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 2018

Chairman: Venkateswarlu Jasti

Managing Director: Venkateswarlu Jasti

Group: --

Listing: NSE: SUVENPHAR, BSE: 543064

Headquarters: Hyderabad, Telangana

Website: www.suvenpharm.com

Key Facts

Market cap: R 12,975.18 Cr

Revenue (TTM): R 1,098.89 Cr

Earnings (TTM): R 323.03 Cr

Cash: R 190.25 Cr

Total Debt: R 141.23 Cr

Promoters' ownership: 60.00%

Liquidity: High

52 Week range: R 450.00 - 590.00

Face value: R1.00

Shares outstanding: 25,45,64,956

Stock Performance

Time Period Suven Pharmaceuticals S&P BSE Healthcare S&P BSE Mid Cap
YTD3.76-9.04-3.14
1 month4.69-6.25-1.89
3 months-0.29-4.45-4.16
1 Year11.3213.5932.83
3 Years--20.3818.82
5 Years--9.7213.27
10 Years--14.2915.19
As on 28-Jan-2022
Year Suven Pharmaceuticals S&P BSE Mid Cap S&P BSE Healthcare
20216.5739.1820.87